Compound 409
Identifiers
- Canonical SMILES:
CC(=O)N(CCSc1ccccc1)c1ccc(cc1S(=O)(=O)C(C)(C)C)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2cc(F)ccc2-c2ccc(Cl)cc2)CC1
- InChi:
InChI=1S/C45H50ClFN6O5S3/c1-31(54)53(24-25-59-37-8-6-5-7-9-37)42-17-15-38(27-43(42)60(55,56)45(2,3)4)61(57,58)50-44-40-20-23-52(29-41(40)48-30-49-44)36-18-21-51(22-19-36)28-33-26-35(47)14-16-39(33)32-10-12-34(46)13-11-32/h5-17,26-27,30,36H,18-25,28-29H2,1-4H3,(H,48,49,50)
- InChiKey:
XDAARKOCPDBNPB-UHFFFAOYSA-N
External links
168318221 |
External search
Bibliography (1)
Publication | Name |
---|---|
Karen Miller-Moslin, Bakary-Barry Toure, Michael Scott Visser, Naeem Yusuff, Novartis Ag. . Sulfonamides as inhibitors of bcl-2 family proteins for the treatment of cancer None. | 15 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 6.12 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 904.27 g/mol | |||
HBA | 11 | |||
HBD | 1 | |||
HBA + HBD | 12 | |||
AlogP | 5.71 | |||
TPSA | 132.88 | |||
RB | 13 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011029842 | 15 | BCL2 P10415 |
|
Biochemical assay | Surface Plasmon Resonance | pIC50 (half maximal inhibitory concentration, -log10) | 6.12 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4303 | Navitoclax | DB12340 | |
0.4136 | GDC-0349 | DB13072 | |
0.4097 | N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE | DB06899 | |
0.4000 | Sparsentan | DB12548 | |
0.3895 | N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE | DB07800 | |
0.3893 | PF-232798 | DB14813 | |
0.3846 | Sulfaisodimidine | DB13283 | |
0.3780 | Presatovir | DB12165 | |
0.3750 | TAK-901 | DB12756 | |
0.3729 | 4-[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE | DB04673 | |
0.3708 | Lenacapavir | DB15673 | |
0.3705 | ABT-639 | DB15055 | |
0.3648 | PF-5190457 | DB14870 | |
0.3627 | Talotrexin | DB06178 | |
0.3615 | Quinupristin | DB01369 |